UPDATE: Morgan Stanley Downgrades Clorox on EPS Risk, Muted Long-Term Growth

Loading...
Loading...
In a report published Thursday, Morgan Stanley analyst Dara Mohsenian downgraded the rating on
The Clorox Co.CLX
from Equal-Weight to Underweight, but named an $83.00 price target. In the report, Morgan Stanley noted, “We are downgrading CLX to UW. Slowing US consumer spending and heightened competitive pressure create near-term EPS risk that we think is not reflected in valuation, particularly as CLX's LT EPS growth potential is more muted than peers'.” The Clorox Co. closed on Wednesday at $85.68.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesAnalyst RatingsDara MohsenianMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...